Process View
The cellular and vascular changes occurring in the endometrium of the pregnant uterus just after the onset of blastocyst implantation. This process involves the proliferation and differentiation of the fibroblast-like endometrial stromal cells into large, polyploid decidual cells that eventually form the maternal component of the placenta.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "decidualization"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.779 | ||
| PLAU | plasminogen activator, urokinase | 0.488 | ||
| JUN | jun proto-oncogene | 0.130 | ||
| RARA | retinoic acid receptor, alpha | 0.115 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.103 | ||
| RXRA | retinoid X receptor, alpha | 0.092 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.083 | ||
| RANBP3 | RAN binding protein 3 | 0.074 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.072 | ||
| SMAD3 | SMAD family member 3 | 0.067 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.062 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.059 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.049 | ||
| FOSL1 | FOS-like antigen 1 | 0.049 | ||
| ARHGEF40 | Rho guanine nucleotide exchange factor (GEF) 40 | 0.048 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.048 | ||
| PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.045 | ||
| HR | hairless homolog (mouse) | 0.040 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.035 | ||
| PLAT | plasminogen activator, tissue | 0.034 | ||
| SOCS2 | suppressor of cytokine signaling 2 | 0.033 | ||
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.032 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.031 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.031 | ||
| APLP2 | amyloid beta (A4) precursor-like protein 2 | 0.030 | ||
| SKIL | SKI-like oncogene | 0.030 | ||
| NPC2 | Niemann-Pick disease, type C2 | 0.028 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.028 | ||
| EP300 | E1A binding protein p300 | 0.027 | ||
| ANXA2 | annexin A2 | 0.027 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.026 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.025 | ||
| TFAP2C | transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | 0.024 | ||
| SPHK1 | sphingosine kinase 1 | 0.023 | ||
| CSTA | cystatin A (stefin A) | 0.023 | ||
| JUND | jun D proto-oncogene | 0.023 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.023 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.023 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.021 | ||
| SMAD9 | SMAD family member 9 | 0.021 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.021 | ||
| DEDD | death effector domain containing | 0.020 | Mouse | |
| CXXC5 | CXXC finger protein 5 | 0.020 | ||
| CCND1 | cyclin D1 | 0.020 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.019 | ||
| EPO | erythropoietin | 0.019 | ||
| TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 0.019 | ||
| BATF2 | basic leucine zipper transcription factor, ATF-like 2 | 0.018 | ||
| IL8 | interleukin 8 | 0.018 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.018 | ||
| ORM1 | orosomucoid 1 | 0.018 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.018 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.017 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.017 | ||
| FOSL2 | FOS-like antigen 2 | 0.017 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.016 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.016 | ||
| PVR | poliovirus receptor | 0.016 | ||
| GRN | granulin | 0.016 | ||
| STC1 | stanniocalcin 1 | 0.015 | Rat | |
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.015 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.015 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.015 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.015 | ||
| MED25 | mediator complex subunit 25 | 0.015 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.014 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.014 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.014 | ||
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.014 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.014 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.014 | Human | |
| CREBBP | CREB binding protein | 0.014 | ||
| TRIB1 | tribbles homolog 1 (Drosophila) | 0.014 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.013 | ||
| CARHSP1 | calcium regulated heat stable protein 1, 24kDa | 0.013 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.013 | ||
| RAB5C | RAB5C, member RAS oncogene family | 0.013 | ||
| VEGFA | vascular endothelial growth factor A | 0.013 | ||
| PTHLH | parathyroid hormone-like hormone | 0.013 | ||
| ATF3 | activating transcription factor 3 | 0.013 | ||
| IL1B | interleukin 1, beta | 0.013 | ||
| SERTAD1 | SERTA domain containing 1 | 0.013 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.013 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.013 | ||
| AR | androgen receptor | 0.013 | ||
| SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.012 | ||
| IER2 | immediate early response 2 | 0.012 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.012 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.012 | ||
| CCND2 | cyclin D2 | 0.012 | ||
| PGR | progesterone receptor | 0.012 | ||
| C6orf106 | chromosome 6 open reading frame 106 | 0.012 | ||
| NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 0.012 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.012 | ||
| SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.012 | ||
| ADIPOR1 | adiponectin receptor 1 | 0.012 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.011 | ||
| S100A10 | S100 calcium binding protein A10 | 0.011 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.011 | ||
| LIFR | leukemia inhibitory factor receptor alpha | 0.011 | ||
| INHBA | inhibin, beta A | 0.011 | ||
| NR1H3 | nuclear receptor subfamily 1, group H, member 3 | 0.011 | ||
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.011 | ||
| RUNX1 | runt-related transcription factor 1 | 0.011 | ||
| SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 | 0.011 | ||
| MCM3AP | minichromosome maintenance complex component 3 associated protein | 0.011 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.011 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.011 | ||
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.011 | ||
| NEU1 | sialidase 1 (lysosomal sialidase) | 0.011 | ||
| SMARCC2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 | 0.011 | ||
| CTSD | cathepsin D | 0.011 | ||
| PTGES | prostaglandin E synthase | 0.011 | ||
| KCNE4 | potassium voltage-gated channel, Isk-related family, member 4 | 0.011 | ||
| EPHA2 | EPH receptor A2 | 0.011 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.010 | ||
| HMOX1 | heme oxygenase (decycling) 1 | 0.010 | ||
| ADAM11 | ADAM metallopeptidase domain 11 | 0.010 | ||
| GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.010 | ||
| ATXN3 | ataxin 3 | 0.010 | ||
| CLCF1 | cardiotrophin-like cytokine factor 1 | 0.010 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.010 | ||
| CISH | cytokine inducible SH2-containing protein | 0.010 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.010 | ||
| TUBB2B | tubulin, beta 2B | 0.010 | ||
| PTN | pleiotrophin | 0.010 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.010 |